Maxim N. Artyomov
- Immunology top 0.1%
- Molecular Biology top 1%
- Epidemiology top 1%
- Neurology top 0.2%
- Oncology top 1%
- Co-authors
- Stanley Ching‐Cheng HuangEdward J. PearceAlexey SergushichevEkaterina LoginichevaBart EvertsYulia IvanovaLuke O'neillVicky Lampropoulou
- Topics
- Immune Cell Function and Interaction (30 papers)Immune cells in cancer (25 papers)T-cell and B-cell Immunology (24 papers)
- Partner nations
- United StatesRussiaGermany
In The Last Decade
Maxim N. Artyomov
134 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Immunology 8.3k
- Molecular Biology 5.7k
- Epidemiology 2.2k
- Neurology 1.8k
- Oncology 1.8k
Countries citing papers authored by Maxim N. Artyomov
This map shows the geographic impact of Maxim N. Artyomov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim N. Artyomov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim N. Artyomov more than expected).
Fields of papers citing papers by Maxim N. Artyomov
This network shows the impact of papers produced by Maxim N. Artyomov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim N. Artyomov. The network helps show where Maxim N. Artyomov may publish in the future.
Co-authorship network of co-authors of Maxim N. Artyomov
This figure shows the co-authorship network connecting the top 25 collaborators of Maxim N. Artyomov. A scholar is included among the top collaborators of Maxim N. Artyomov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim N. Artyomov. Maxim N. Artyomov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 19 | |
| 4 | 14 | |
| 5 | 16 | |
| 6 | 0 | |
| 7 | 5 | |
| 8 | 8 | |
| 9 | 11 | |
| 10 | 14 | |
| 11 | 93 | |
| 12 | 84 | |
| 13 | 11 | |
| 14 | 30 | |
| 15 | 213 | |
| 16 | 34 | |
| 17 | 200 | |
| 18 | The microbial metabolite desaminotyrosine protects from influenza through type I interferonbreakdown → | 403 |
| 19 | 80 | |
| 20 | 324 |
About Maxim N. Artyomov
Maxim N. Artyomov is a scholar working on Immunology, Neurology and Biological Psychiatry, having authored 136 papers that have together received 15.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (30 papers), Immune cells in cancer (25 papers) and T-cell and B-cell Immunology (24 papers). The work is most often cited by research in Immunology (8.3k citations), Neurology (1.8k citations) and Biological Psychiatry (531 citations). Maxim N. Artyomov has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Stanley Ching‐Cheng Huang, Edward J. Pearce, Alexey Sergushichev, Ekaterina Loginicheva, Bart Everts, Yulia Ivanova, Luke O'neill, Vicky Lampropoulou, Irina Shchukina and Robert D. Schreiber. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.